Related references
Note: Only part of the references are listed.Low-dose anti-thymocyte globulin for GVHD prophylaxis in HLA-matched allogeneic peripheral blood stem cell transplantation
Souichi Shiratori et al.
BONE MARROW TRANSPLANTATION (2021)
Personalizing rabbit anti-thymocyte globulin therapy for prevention of graft-versus-host disease after allogeneic hematopoietic cell transplantation: is there an optimal dose?
Takafumi Shichijo et al.
BONE MARROW TRANSPLANTATION (2020)
Does Lymphocyte Count Impact Dosing of Anti-Thymocyte Globulin in Unrelated Donor Stem Cell Transplantation?
Francine Heelan et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2020)
Prophylaxis and management of graft versus host disease after stem-cell transplantation for haematological malignancies: updated consensus recommendations of the European Society for Blood and Marrow Transplantation
Olaf Penack et al.
Lancet Haematology (2020)
Clinical outcomes with low dose anti-thymocyte globulin in patients undergoing matched unrelated donor allogeneic hematopoietic cell transplantation
Luke Mountjoy et al.
LEUKEMIA & LYMPHOMA (2020)
Preconditioning Absolute Lymphocyte Count and Transplantation Outcomes in Matched Related Donor Allogeneic Hematopoietic Stem Cell Transplantation Recipients with Reduced-Intensity Conditioning and Antithymocyte Globulin Treatment
Go-Un Woo et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2020)
Acute GVHD prophylaxis plus ATLG after myeloablative allogeneic haemopoietic peripheral blood stem-cell transplantation from HLA-identical siblings in patients with acute myeloid leukaemia in remission: final results of quality of life and long-term outcome analysis of a phase 3 randomised study
Francesca Bonifazi et al.
LANCET HAEMATOLOGY (2019)
Low dose anti-thymocyte globulin reduces chronic graft-versus-host disease incidence rates after matched unrelated donor transplantation
Anand Tandra et al.
LEUKEMIA & LYMPHOMA (2018)
Optimizing Antithymocyte Globulin Dosing for Unrelated Donor Allogeneic Hematopoietic Cell Transplantation Based on Recipient Absolute Lymphocyte Count
Vanessa E. Kennedy et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2018)
Beneficial impact of low-dose rabbit anti-thymocyte globulin in unrelated hematopoietic stem cell transplantation: focusing on difference between stem cell sources
Takafumi Shichijo et al.
BONE MARROW TRANSPLANTATION (2018)
T-cell depletion effects of low-dose antithymocyte globulin for GVHD prophylaxis in HLA-matched allogeneic peripheral blood stem cell transplantation
Souichi Shiratori et al.
TRANSPLANT IMMUNOLOGY (2018)
Low-dose anti-thymocyte globulin reduce severe acute and chronic graft-versus-host disease after allogeneic stem cell transplantation
Osamu Imataki et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2017)
Prospective, Randomized, Double-Blind, Phase III Clinical Trial of Anti-T-Lymphocyte Globulin to Assess Impact on Chronic Graft-Versus-Host Disease-Free Survival in Patients Undergoing HLA-Matched Unrelated Myeloablative Hematopoietic Cell Transplantation
Robert J. Soiffer et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Impact of in vivo T cell depletion in HLA-identical allogeneic stem cell transplantation for acute myeloid leukemia in first complete remission conditioned with a fludarabine iv-busulfan myeloablative regimen: a report from the EBMT Acute Leukemia Working Party
Marie Therese Rubio et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2017)
Long-term outcomes after standard graft-versus-host disease prophylaxis with or without anti-human-T-lymphocyte immunoglobulin in haemopoietic cell transplantation from matched unrelated donors: final results of a randomised controlled trial
Juergen Finke et al.
LANCET HAEMATOLOGY (2017)
Association between anti-thymocyte globulin exposure and survival outcomes in adult unrelated haemopoietic cell transplantation: a retrospective, pharmacodynamic cohort analysis
Rick Admiraal et al.
LANCET HAEMATOLOGY (2017)
Low-Dose Antithymocyte Globulin for Graft-versus-Host-Disease Prophylaxis in Matched Unrelated Allogeneic Hematopoietic Stem Cell Transplantation
Adam Bryant et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2017)
Impact of low-dose rabbit anti-thymocyte globulin in unrelated hematopoietic stem cell transplantation
Kodai Kuriyama et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2016)
Pretreatment with anti-thymocyte globulin versus no anti-thymocyte globulin in patients with haematological malignancies undergoing haemopoietic cell transplantation from unrelated donors: a randomised, controlled, open-label, phase 3, multicentre trial
Irwin Walker et al.
LANCET ONCOLOGY (2016)
Antilymphocyte Globulin for Prevention of Chronic Graft-versus-Host Disease
Nicolaus Kroeger et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Validation and refinement of the Disease Risk Index for allogeneic stem cell transplantation
Philippe Armand et al.
BLOOD (2014)
Investigation of the freely available easy-to-use software 'EZR' for medical statistics
Y. Kanda
BONE MARROW TRANSPLANTATION (2013)
Standard graft-versus-host disease prophylaxis with or without anti-T-cell globulin in haematopoietic cell transplantation from matched unrelated donors: a randomised, open-label, multicentre phase 3 trial
Juergen Finke et al.
LANCET ONCOLOGY (2009)
Hematopoietic cell transplantation-specific comorbidity index as an outcome predictor for patients with acute myeloid leukemia in first remission: combined FHCRC and MDACC experiences
Mohamed L. Sorror et al.
BLOOD (2007)
National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report
AH Filipovich et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2005)
Share Paper
